Their popularity as a tool for weight loss skyrocketed after the US Food and Drug Administration (FDA) approved semaglutide for weight management in 2021
Weight Loss Significant weight loss Reduced waist size Lasting results Cardiovascular Health Lower cardiac risk Better blood pressure Improved waist ratio Metabolic Function Steadier blood sugar Better insulin response Healthier cholesterol Appetite Control Quieter cravings Smaller portions Fewer food thoughts Lose weight on your terms
GLP-1 medications tested as well About half of the patients studied took newer GLP-1 drugs like semaglutide, sold as Ozempic and Wegovy, as well as tirzepatide, which is sold as Mounjaro and Zepbound
Hogan AE, Gaoatswe G, Lynch L, Corrigan MA, Woods C, OConnell J, et al
& Doenhoff, M
Energizes skin cells and reduces signs of aging